AriBioLab Co.,Ltd. (KOSDAQ:261780)
South Korea · Delayed Price · Currency is KRW 3,515.00
+70.00 (2.03%)
At close: Sep 23, 2026
AriBioLab Market Cap
AriBioLab has a market cap or net worth of 98.47 billion as of September 25, 2026. Its market cap has increased by 33.53% in one year.
Market Cap
98.47B
Enterprise Value
89.02B
Revenue
173.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,515.00
ChartMarket Cap Chart
Since October 22, 2021, AriBioLab's market cap has decreased from 343.58B to 98.47B, a decrease of -71.34%. That is a compound annual growth rate of -22.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 98.47B | 29.74% |
| Dec 30, 2025 | 75.89B | -7.54% |
| Dec 30, 2024 | 82.08B | -45.65% |
| Dec 28, 2023 | 151.04B | 14.64% |
| Dec 29, 2022 | 131.75B | -55.09% |
| Dec 30, 2021 | 293.36B | -14.62% |
| Oct 22, 2021 | 343.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TiumBio | 133.37B |
| Y-Biologics | 128.16B |
| ViGenCell | 117.26B |
| Prestige Biologics | 106.05B |
| Cell Biotech | 102.11B |
| CORESTEMCHEMON | 94.27B |
| Choong Ang Vaccine Laboratory | 84.70B |
| EyeGene | 84.30B |